AltraBio is participating in this initiative, which has 15 partners and a global budget of more than 2.6 million euros
March 15, 2023, France – This project, called SIGNATURE (SInGle cells iN AuToimmUne inflammatoRy disEases), is part of the Marie Skłodowska-Curie Actions Programme and the Horizon Europe programme, the European Union’s R&D&I plan. This international network will train enterprising, innovative and resilient doctoral students, capable of facing current and future challenges and turning knowledge and ideas into products and services for economic and social benefit.
SIGNATURE is led by the Fundación Pública Andaluza Progreso y Salud in Spain, and more specifically by the researchers Marta Alarcón Riquelme and Concepción Marañón Lizana. AltraBio has been collaborating with the foundation for 5 years, including in the framework of other large-scale European projects for research on autoimmune diseases and the development of precision medicine. Thirteen other partners are part of the network, including the academic partners such as University of Western Brittany in France, the Flemish Institute of Biotechnology in the Netherlands, the German Rheumatism Research Centre in Germany and the University of Catania in Italy, among others. Biotechnological companies such as Atrys Health and Altrabio are also actively participating in the network. To know more
